Skip to main content
. 2022 Aug 8;12:922332. doi: 10.3389/fonc.2022.922332

Figure 4.

Figure 4

Cuproptosis-related gene model predicts the clinical outcomes of LUAD patients. (A) Kaplan-Meier curves of LUAD subgroups divided by cuproptosis-related gene model. (B, C) Cuproptosis-related gene model predictive of poor overall survival among patients older than 65 years and smoking history. (D) Nomogram showing the efficacies of cuproptosis-related gene model for predicting the RFS of 1, 3, and 5 years in LUAD patients. (E) Calibration curves of the nomogram for predicting 1-, 3-, and 5-year OS in LUAD samples. (F, G) A risk prediction model based on the cuproptosis-related gene set.